Showing 8001-8010 of 10544 results for "".
- MyHealthTeams, Global Vitiligo Foundation Team Up to Create New Social Networkhttps://practicaldermatology.com/news/myhealthteams-global-vitiligo-foundation-team-up-to-create-new-social-network/2460293/
- Revian Awarded Patent for Biostimulatory Light Combinationshttps://practicaldermatology.com/news/revian-awarded-patent-for-biostimulatory-light-technology/2460249/Revian Inc. has received from the United States Patent and Trademark Office (USPTO) U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the u
- The HydraFacial Company Takes on Scalp Healthhttps://practicaldermatology.com/news/the-hydrafacial-company-takes-on-scalp-health/2460245/The HydraFacial Company is launching
- Defective Stem Cell Behavior Linked to Psoriasishttps://practicaldermatology.com/news/defective-stem-cell-behavior-linked-to-psoriasis/2460233/Investigators from
- AbbVie Launches “Let Me Be Clear” to Urge Psoriasis Patients to Speak Uphttps://practicaldermatology.com/news/abbvie-launches-let-me-be-clear-to-urge-psoriasis-patients-to-speak-up/2460202/AbbVie is launching Let Me Be
- Meet Ortho Derm’s 2019 Aspire Higher Scholarship Winnershttps://practicaldermatology.com/news/meet-ortho-derms-2019-aspire-higher-scholarship-winners/2460177/Ortho Dermatologics
- Melanoma Breakthrough: Researchers Discover Why Some Patients Respond to Immunotherapyhttps://practicaldermatology.com/news/melanoma-breakthrough-researchers-discover-why-some-patients-respond-to-immunotherapy-yet-others-dont/2460143/Israeli researchers now know why 60 percent of patients with metastatic melanoma do not respond to immunotherapy. After examining tumors of 116 patients using proteomics, the researchers found the non-responding patients tended to have lower fatty acid metabolism, meaning that their enz
- Duobrii Lotion for Plaque Psoriasis Hits Shelveshttps://practicaldermatology.com/news/duobrii-lotion-for-plaque-psoriasis-hits-shelves/2460079/Ortho Dermatologics’ Duobrii (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045%, is now available. Approved by the U.S. Food and Drug Administration on April 25, 2019, Duobrii is the first and only topical lotion that contains a uniq
- MoleSafe USA Launches Interactive Challenge for Skin Cancer Awareness Monthhttps://practicaldermatology.com/news/molesafe-usa-launches-interactive-challenge-for-skin-cancer-awareness-month/2460019/MoleSafe USA, LLC is launching an interactive, online
- InMode Launches AccuTite, the Smallest RFAL Treatment for Face and Bodyhttps://practicaldermatology.com/news/inmode-launches-accutite-the-smallest-rfal-treatment-for-face-and-body/2460000/InMode Ltd